93 related articles for article (PubMed ID: 10716654)
1. Transgenic approaches to model Alzheimer's disease.
Sommer B; Sturchler-Pierrat C; Abramowski D; Wiederhold KH; Calhoun M; Jucker M; Kelly P; Staufenbiel M
Rev Neurosci; 2000; 11(1):47-51. PubMed ID: 10716654
[TBL] [Abstract][Full Text] [Related]
2. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology.
Sturchler-Pierrat C; Abramowski D; Duke M; Wiederhold KH; Mistl C; Rothacher S; Ledermann B; Bürki K; Frey P; Paganetti PA; Waridel C; Calhoun ME; Jucker M; Probst A; Staufenbiel M; Sommer B
Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13287-92. PubMed ID: 9371838
[TBL] [Abstract][Full Text] [Related]
3. Transgenic mouse models of Alzheimer's disease.
Bornemann KD; Staufenbiel M
Ann N Y Acad Sci; 2000 Jun; 908():260-6. PubMed ID: 10911965
[TBL] [Abstract][Full Text] [Related]
4. Exclusive association and simultaneous appearance of congophilic plaques and AT8-positive dystrophic neurites in Tg2576 mice suggest a mechanism of senile plaque formation and progression of neuritic dystrophy in Alzheimer's disease.
Noda-Saita K; Terai K; Iwai A; Tsukamoto M; Shitaka Y; Kawabata S; Okada M; Yamaguchi T
Acta Neuropathol; 2004 Nov; 108(5):435-42. PubMed ID: 15372280
[TBL] [Abstract][Full Text] [Related]
5. Advanced glycation endproducts and pro-inflammatory cytokines in transgenic Tg2576 mice with amyloid plaque pathology.
Münch G; Apelt J; Rosemarie-Kientsch-Engel ; Stahl P; Lüth HJ; Schliebs R
J Neurochem; 2003 Jul; 86(2):283-9. PubMed ID: 12871569
[TBL] [Abstract][Full Text] [Related]
6. The pathology of APP transgenic mice: a model of Alzheimer's disease or simply overexpression of APP?
Howlett DR; Richardson JC
Histol Histopathol; 2009 Jan; 24(1):83-100. PubMed ID: 19012248
[TBL] [Abstract][Full Text] [Related]
7. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway.
Jaffar S; Counts SE; Ma SY; Dadko E; Gordon MN; Morgan D; Mufson EJ
Exp Neurol; 2001 Aug; 170(2):227-43. PubMed ID: 11476589
[TBL] [Abstract][Full Text] [Related]
8. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
Kuznetsova E; Schliebs R
Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
[TBL] [Abstract][Full Text] [Related]
9. Cholinergic neuropathology in a mouse model of Alzheimer's disease.
German DC; Yazdani U; Speciale SG; Pasbakhsh P; Games D; Liang CL
J Comp Neurol; 2003 Aug; 462(4):371-81. PubMed ID: 12811807
[TBL] [Abstract][Full Text] [Related]
10. Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.
Ferrer I; Gomez-Isla T; Puig B; Freixes M; Ribé E; Dalfó E; Avila J
Curr Alzheimer Res; 2005 Jan; 2(1):3-18. PubMed ID: 15977985
[TBL] [Abstract][Full Text] [Related]
11. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
[TBL] [Abstract][Full Text] [Related]
12. Pathogenic mechanisms of Alzheimer's disease analyzed in the APP23 transgenic mouse model.
Sturchler-Pierrat C; Staufenbiel M
Ann N Y Acad Sci; 2000; 920():134-9. PubMed ID: 11193142
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer's pathology.
Haure-Mirande JV; Audrain M; Fanutza T; Kim SH; Klein WL; Glabe C; Readhead B; Dudley JT; Blitzer RD; Wang M; Zhang B; Schadt EE; Gandy S; Ehrlich ME
Acta Neuropathol; 2017 Nov; 134(5):769-788. PubMed ID: 28612290
[TBL] [Abstract][Full Text] [Related]
14. Melatonin alleviates behavioral deficits associated with apoptosis and cholinergic system dysfunction in the APP 695 transgenic mouse model of Alzheimer's disease.
Feng Z; Chang Y; Cheng Y; Zhang BL; Qu ZW; Qin C; Zhang JT
J Pineal Res; 2004 Sep; 37(2):129-36. PubMed ID: 15298672
[TBL] [Abstract][Full Text] [Related]
15. Modeling Alzheimer's disease in transgenic mice: effect of age and of presenilin1 on amyloid biochemistry and pathology in APP/London mice.
Dewachter I; van Dorpe J; Spittaels K; Tesseur I; Van Den Haute C; Moechars D; Van Leuven F
Exp Gerontol; 2000 Sep; 35(6-7):831-41. PubMed ID: 11053674
[TBL] [Abstract][Full Text] [Related]
16. Age-dependent behavioral and biochemical characterization of single APP knock-in mouse (APP
Mehla J; Lacoursiere SG; Lapointe V; McNaughton BL; Sutherland RJ; McDonald RJ; Mohajerani MH
Neurobiol Aging; 2019 Mar; 75():25-37. PubMed ID: 30508733
[TBL] [Abstract][Full Text] [Related]
17. Increased Vulnerability of the Hippocampus in Transgenic Mice Overexpressing APP and Triple Repeat Tau.
Arner A; Rockenstein E; Mante M; Florio J; Masliah D; Salehi B; Adame A; Overk C; Masliah E; Rissman RA
J Alzheimers Dis; 2018; 61(3):1201-1219. PubMed ID: 29332037
[TBL] [Abstract][Full Text] [Related]
18. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.
Pérez M; Morán MA; Ferrer I; Avila J; Gómez-Ramos P
Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696
[TBL] [Abstract][Full Text] [Related]
20. Serum β-amyloid peptide levels spike in the early stage of Alzheimer-like plaque pathology in an APP/PS1 double transgenic mouse model.
He J; Qiao JP; Zhu S; Xue M; Chen W; Wang X; Tempier A; Huang Q; Kong J; Li XM
Curr Alzheimer Res; 2013 Nov; 10(9):979-86. PubMed ID: 24117120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
